Keymed Biosciences Inc. (HKG:2162)
60.55
+2.90 (5.03%)
At close: Mar 27, 2026
48.95% (1Y)
| Market Cap | 17.84B +76.8% |
| Revenue (ttm) | 797.12M +67.3% |
| Net Income | -581.60M |
| EPS | -2.13 |
| Shares Out | 294.60M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,423,500 |
| Average Volume | 2,270,266 |
| Open | 57.65 |
| Previous Close | 57.65 |
| Day's Range | 56.35 - 61.00 |
| 52-Week Range | 34.15 - 80.00 |
| Beta | -0.10 |
| RSI | 65.33 |
| Earnings Date | Mar 26, 2026 |